Author

Gerhard H. A. Seemann

Observed names: G H A Seemann, G Seemann, G. Seemann, G.H. Seemann, Gerhard Seemann

Observed institutions: The Netherlands Cancer Institute, Behringwerke (Germany)

OpenAlex ID: A5026521986

The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.

1987 · D Güssow, R Rein, et al. · The Journal of Immunology · 318

Isolation, expression, and the primary structure of HLA-Cw1 and HLA-Cw2 genes: Evolutionary aspects

1987 · Detlef Güssow, Rita S. Rein, et al. · Immunogenetics · 136

Molecular and functional characterisation of a fusion protein suited for tumour specific prodrug activation

1992 · K Bosslet, J Czech, et al. · British Journal of Cancer · 102

PDF

Gene conversion‐like mechanisms may generate polymorphism in human class I genes.

1986 · G.H. Seemann, R.S. Rein, et al. · The EMBO Journal · 92

Association with beta 2-microglobulin controls the expression of transfected human class I genes.

1987 · R S Rein, G H A Seemann, et al. · The Journal of Immunology · 59

DNA sequence of the coding region of the HLA-B44 gene

1986 · Andreas H. Kottmann, Gerhard H. A. Seemann, et al. · Immunogenetics · 53

[5] Humanization of monoclonal antibodies

1991 · Detlef Güssow, Gerhard Seemann · Methods in enzymology on CD-ROM/Methods in enzymology · 48

Generation of bispecific monoclonal antibodies for two phase radioimmunotherapy

1991 · K Bosslet, A Steinstraesser, et al. · British Journal of Cancer · 21

The Change in Research for the Therapy of Tumors

1991 · H.-Harald Sedlacek, Dieter Hoffmann, et al. · CHIMIA International Journal for Chemistry · 17

PDF

Characterisation of a humanised bispecific monoclonal antibody for cancer therapy

1993 · A Bruynck, G Seemann, et al. · British Journal of Cancer · 16

Development, validation and practical use of a sensitive and specific radioimmunoassay for the determination of iloprost.

1990 · M Hildebrand, B Nieuweboer, et al. · PubMed · 16

Fusion protein mediated prodrug activation (FMPA) in vivo

1994 · K. Bosslet, J. Czech, et al. · Cell Biophysics · 13

Humanized anti-carcinoembryonic antigen antibody: strategies to enhance human tumor cell killing.

1993 · H Kaulen, G Seemann, et al. · PubMed · 13

Immunological tailoring of monoclonal antibodies for immunotherapy of pancreatic carcinoma

1988 · K. Bosslet, N. Döring, et al. · International Journal of Cancer · 6

A highly specific radioimmunological determination of sulprostone using antisera against two different haptens

1982 · B. Nieuweboer, K. Schmidt-Gollwitzer, et al. · Prostaglandins Leukotrienes and Medicine · 5

Recombinant monoclonal antibodies in tumor therapy.

1990 · G Seemann, K Bosslet, et al. · PubMed · 3

Isolation, expression, and the primary structure of HLA-Cw1 and HLA-Cw2 genes: evolutionary aspects

1988 · Detlef Güssow, Rita S. Rein, et al. · Immunogenetics · 2

PDF

Specific Radioimmunotherapy

1988 · H.H. Sedlacek, G. Schulz, et al. · Beiträge zur Onkologie/Contributions to oncology · 1

Bispecific Monoclonal Antibodies for two Phase Radioimmunotherapy

1991 · K. Bosslet, A. Steinstraesser, et al. · Springer eBooks

Two-phase radioimmunotherapy using bispecific monoclonal antibodies (bs MAbs)

1990 · K. Bosslet, P. Hermentin, et al. · Cancer Treatment Reviews

Generation, Selection, Properties and Quality Control of Murine Monoclonal Antibodies

1988 · H.H. Sedlacek, G. Schulz, et al. · Beiträge zur Onkologie/Contributions to oncology

Tumor Antigens

1988 · H.H. Sedlacek, G. Schulz, et al. · Beiträge zur Onkologie/Contributions to oncology

3 Human antitumor antibodies: Problems, opportunities

1987 · G. Seemann, K. Bosslet, et al. · Journal of Steroid Biochemistry

Works count: 24

Citation count: 921

H-index: 13

I10-index: 13